| Line Item | 2025-11-30 | Y/Y |
|---|---|---|
| Revenue | $84.0M | +54.0% |
| R&D Expense | $316.9M | +43.0% |
| SG&A Expense | $52.7M | +14.8% |
| Operating Income | -$285.7M | -34.1% |
| Pre-tax Income | -$263.7M | -36.4% |
| Income Tax | $760K | +181.5% |
| Net Income | -$264.5M | -36.6% |
| EPS (Basic) | -$3.05 | -5.9% |
| EPS (Diluted) | -$3.05 |
| Line Item | 2025-11-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $247.0M | +124.5% |
| Current Assets | $606.8M | -2.0% |
| Total Assets | $688.1M | +2.8% |
| Current Liabilities | $86.5M | -9.8% |
| Total Liabilities | $149.4M | +4.9% |
| Stockholders' Equity | $538.7M | +2.2% |
| Line Item | 2025-11-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$249.5M | -44.5% |
| Capital Expenditures | $14.0M | +51.0% |
| Investing Cash Flow | $147.9M | +157.4% |
| Financing Cash Flow | $238.6M | -50.9% |
| Free Cash Flow | -$263.5M | -44.9% |
| -5.9% |